Trials / Completed
CompletedNCT03586102
Effect of Increased Enteral Protein on Body Composition of Preterm Infants
Effect of Increased Enteral Protein on Body Composition of Preterm Infants: A Randomized Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- University of Alabama at Birmingham · Academic / Other
- Sex
- All
- Age
- 1 Day – 21 Days
- Healthy volunteers
- Not accepted
Summary
The study hypothesis is that, in human milk-fed extremely preterm infants, higher protein intake compared to usual protein intake reduces percent body fat (%BF) at 3 months of age.
Detailed description
Qualifying participants will be randomly assigned to receive either standard protein supplementation (control group) or high protein supplementation (intervention group). Intervention group: A fixed amount of commercially available hydrolyzed bovine protein will be added to fortified human milk after establishment of full enteral feeding. Control group: Hydrolyzed bovine protein will not be added to fortified human milk after establishment of full enteral feeding. If parent agrees, stool "dirty" diapers will be collected 2 times (at the time of hospital discharge and at 3 months of corrected age).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | High protein supplementation | To increase protein content of human milk, a fixed amount of commercially available hydrolyzed bovine protein will be added to fortified human milk. With this pragmatic approach, preterm infants assigned to the high protein supplementation group will receive \> 4.5 g/kg/day of enteral protein after establishment of full enteral feeding. |
| DIETARY_SUPPLEMENT | Standard protein supplementation | Infants assigned to the standard protein supplementation group will receive fortified human milk (\< 4.5 g/kg/day of enteral protein) |
Timeline
- Start date
- 2018-08-23
- Primary completion
- 2020-04-30
- Completion
- 2025-04-24
- First posted
- 2018-07-13
- Last updated
- 2025-05-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03586102. Inclusion in this directory is not an endorsement.